The chemical defensive system in the pathobiology of idiopathic environment-associated diseases.
Chemical defensive system consisting of bio-sensoring, transmitting, and responsive elements has been evolved to protect multi-cellular organisms against environmental chemical insults (xenobiotics) and to maintain homeostasis of endogenous low molecular weight metabolites (endobiotics). Both genetic and epigenetic defects of the system in association with carcinogenesis and individual sensitivity to anti-tumor therapies have been intensely studied. Recently, several non-tumor human pathologies with evident environmental components such as rather rare functional syndromes (multiple chemical sensitivity, chronic fatigue, Persian Gulf, and fibromyalgia now collectively labeled as idiopathic environmental intolerances) and common diseases (vitiligo and systemic lupus erythematosus) have become subjects of the research on the impaired metabolism and detoxification of xenobiotics and endogenous toxins. Here, we collected and critically reviewed epidemiological, genetic, and biochemical data on the involvement and possible role of cytochrome P450 super family enzymes, glutathione-S-transferase isozymes, catechol-O-methyl-transferase, UDP-glucuronosyl transferases, and proteins detoxifying inorganic and organic peroxides (catalase, glutathione peroxidase, and peroxiredoxin) in the above pathologies. Genetic predisposition assessed mainly by single nucleotide polymorphism and gene expression analyses revealed correlations between defects in genes encoding xenobiotic-metabolizing and/or detoxifying enzymes and risk/severity of these syndromes/diseases. Proteome analysis identified abnormal expression of the enzymes. Their functions were affected epigenetically leading to metabolic impairment and, as a consequence, to the negative health outcomes shared by some of these pathologies. Data obtained so far suggest that distinct components of the chemical defensive system could be suitable molecular targets for future pathogenic therapies.
Korkina
L
L
Istituto Dermopatico dell'Immacolata, Rome, Italy. l.korkina@idi.it
Scordo
M G
MG
Deeva
I
I
Cesareo
E
E
De Luca
C
C
D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D020022:Genetic Predisposition to Disease; D006801:Humans; D008658:Inactivation, Metabolic / Q000235:genetics*; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000235:genetics* / Q000378:metabolism; D008954:Models, Biological; D018777:Multiple Chemical Sensitivity / Q000235:genetics* / Q000378:metabolism; D018384:Oxidative Stress / Q000235:genetics; D010545:Peroxides / Q000378:metabolism; D014820:Vitiligo / Q000139:chemically induced / Q000235:genetics* / Q000378:metabolism; D015262:Xenobiotics / Q000009:adverse effects* / Q000493:pharmacokinetics
D010545:Peroxides; D015262:Xenobiotics